Merck
CN
  • Intranasal substituted cathinone "bath salts" psychosis potentially exacerbated by diphenhydramine.

Intranasal substituted cathinone "bath salts" psychosis potentially exacerbated by diphenhydramine.

Journal of addiction medicine (2013-06-05)
Erik W Gunderson, Matthew G Kirkpatrick, Laura M Willing, Christopher P Holstege
摘要

In this report, we describe a case of intranasal "bath salts"-associated psychosis. Symptoms developed during a 3-week binge and were potentially exacerbated by oral diphenhydramine taken for insomnia. The clinical case conference includes expert discussion from 3 disciplines: emergency medicine toxicology, behavioral pharmacology, and addiction medicine. It is hoped that the discussion will provide insight into the clinical aspects and challenges of addressing acute substituted cathinone toxicity, including acute psychosis, a major adverse effect of bath salts consumption.

材料
货号
品牌
产品描述

Supelco
苯海拉明 盐酸盐, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
苯海拉明 盐酸盐, ≥98% (HPLC)
Supelco
盐酸苯海拉明标准液 盐酸盐, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
苯海拉明 盐酸盐, European Pharmacopoeia (EP) Reference Standard